Microbiome-Linked Crosstalk in the Gastrointestinal Exposome towards Host Health and Disease.
10.5223/pghn.2016.19.4.221
- Author:
Yuseok MOON
1
Author Information
1. Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, Pusan National University School of Medicine, Yangsan, Korea. moon@pnu.edu
- Publication Type:Review
- Keywords:
Gastrointestinal exposome;
Microbiota;
Gastrointestinal immunity and inflammation;
Xenobiotic metabolism
- MeSH:
Biological Availability;
Disease Progression;
Gastrointestinal Microbiome;
Humans;
Microbiota;
Mucous Membrane;
Neurosecretory Systems;
Phenobarbital;
Symbiosis;
Xenobiotics
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2016;19(4):221-228
- CountryRepublic of Korea
- Language:English
-
Abstract:
The gastrointestinal exposome represents the integration of all xenobiotic components and host-derived endogenous components affecting the host health, disease progression and ultimately clinical outcomes during the lifespan. The human gut microbiome as a dynamic exposome of commensalism continuously interacts with other exogenous exposome as well as host sentineling components including the immune and neuroendocrine circuit. The composition and diversity of the microbiome are established on the basis of the luminal environment (physical, chemical and biological exposome) and host surveillance at each part of the gastrointestinal lining. Whereas the chemical exposome derived from nutrients and other xenobiotics can influence the dynamics of microbiome community (the stability, diversity, or resilience), the microbiomes reciprocally alter the bioavailability and activities of the chemical exposome in the mucosa. In particular, xenobiotic metabolites by the gut microbial enzymes can be either beneficial or detrimental to the host health although xenobiotics can alter the composition and diversity of the gut microbiome. The integration of the mucosal crosstalk in the exposome determines the fate of microbiome community and host response to the etiologic factors of disease. Therefore, the network between microbiome and other mucosal exposome would provide new insights into the clinical intervention against the mucosal or systemic disorders via regulation of the gut-associated immunological, metabolic, or neuroendocrine system.
